Dr. Taimur Sher, MD

Dr. Sher practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Sher's NPI, 1306171871, was assigned on October 16, 2009. Dr. Sher graduated from King Edward Medical University in 2002. Dr. Sher holds Florida license ME111401.

Dr. Sher's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Sher's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Sher to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sher practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sher's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sher is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Sher's licenses on file in 3 states: Florida, Georgia and New York.

Dmand AI lists anemia, breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Sher treats.

CMS data shows 87,912 Medicare services from Dr. Sher across 63 procedure codes in 2024, for 945 Medicare patients. Medicare paid $1,396,099 for them.

CMS counts 945 Medicare patients who saw Dr. Sher in 2024. The largest group is 65 to 74, with 453 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sher's median patient age at 68, with 44% women.

In 2024, Dr. Sher wrote 110 Medicare Part D claims for 34 patients. 67% of them were for generic drugs. CMS names the drug for 45 of them, across 2 drugs with 11 or more claims each, at $536,804 in total drug cost. In 2023, CMS named 61 claims across 2 drugs.

Dr. Sher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sher as offering telehealth.

Dmand AI links 92 papers to Dr. Sher, published from 2011 to 2025. 2020 was the busiest year, with 13. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Antineoplastic Agents. Dr. Sher has published most often in Leuk Lymphoma. Dr. Sher's most frequent co-authors are Sikander Ailawadhi, MD, Asher A. Chanan-Khan, MD and Vivek Roy, MD.

Dmand AI links Dr. Sher to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Amyloidosis, Immunoglobulin Light-chain Amyloidosis and Leukemia, Lymphocytic, Chronic, B-Cell. Open Payments lists research payments to Dr. Sher that name 1 trial.

CMS Open Payments shows 25 general payments to Dr. Sher from 6 drug and device companies from 2018 to 2021. Consulting fees make up the largest share, 76% of the total. Alnylam Pharmaceuticals Inc. paid the most, $6,424. It also lists 4 research payments totaling $106,834 from 2017 to 2020, naming 1 clinical trial.

Dr. Sher graduated from King Edward Medical University in 2002.

Dr. Sher is in network with 9 carriers, including Excellus BlueCross BlueShield, Elevance and United Healthcare. POS plans come from the most carriers, 4. Check the plan with the practice before a visit.